chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 04-Nov-2021 and the vial did not undergo any temperature excursions. It was reported that, some patients took dose on 05-Nov-2021 and the other patients took dose on 12-Nov-2021.  The patient did not experience any events, because of this misadministration.  No treatment information was provided by the reporter.
pt recvd vax; nausea & vomiting; tx in ofc w/ phenergan, then sent to er for phenergan iv; no previous rxn to td; blood test nl;
I had abdominal pain, across to the liver as well, bloated. That lasted for three weeks. I still have that sometimes.
The morning after I received the Covid vaccine my arm was super sore which was to be expected. But as I?m going about my day, I start to notice the pain was increasing more and more to where it felt like I had a rock or something under my skin. I looked and felt my arm and it was VERY HOT to the touch, super red, and it was the biggest knot ever! Plus my whole upper arm was like a huge hump and extremely swollen. But at the injection site, it felt like a hard medium sized rock was under my skin and when I moved my arm at all or got dressed even, the pain was very extreme. Following the rest of the day, I start noticing that my back and neck began to get sore. I thought nothing of it until it became a nagging pain and I had to sit down and rest and try to relieve the pain. I also have been slightly nauseas and very tired since the day after I received the vaccine. Last thing I noticed was my head pounding. I got such a severe headache that my eyes started to get blurry and they still are. My arm is still very sore as well, but my nausea has subsided for now. It?s only been going on two days post vaccine so we?ll see how long these symptoms last.
SHINGLES; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included shingles. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 28-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced shingles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shingles. This report was non-serious.
I went in I got the shot; I did not have reaction, and everything was fine. I started they symptoms for COVID-19, on Feb 18th, I felt like a cold was coming, I took the home test COVID-19 test, and it was test was positive. No fever, no temperature. I called my doctor he prescribed PAXLOVID, I pick it up next day at the pharmacy.
Convulsions 10/27/21 @11:30pm Muscle pain and cramping  Cold chills Sweats
No additional AEs; expired dose of PNEUMOVAX 23 was administered; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not reported.  On 07-JUL-2022, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) (0.5 mL, subcutaneously (SQ), lot number T020638 and expiration date was reported as 01-FEB-2022, but upon internal validation established as 26-FEB-2022; strength, anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event).
I tested positive for COVID-19 on 3/17/23. I had congestion, sore throat, hard to swallow, fever, fatigue, body aches, loss of taste, and a cough. I contacted my doctor and was prescribed 5 days' worth of PAXLOVID. I feel much better now.
3-10-2010-2:00p reported rash over entire body-syncope in ER-IV started ZANTAC 50 mg IV-EKG norm, D/C at 7:00p 3-10-2010 Rx VISTARIL 25 mg 1 QID PRN, ZANTAC 150 mg 1 BID-to report to own physician in 2-3 days.
I had mild numbness and tingling in both arms and hands.  I also had a raised red lump/rash, again about the size of my fist, starting below the injection site and extending downwards.  Additionally I developed a rash on my chest, which was a bit larger than the one on my arm but not raised, just red.  It was about 2.5? wide and 4? high, right between my breasts.  I?ve never had anything like this before.  It lasted more than a day, but I don?t recall exactly when it finally subsided.
second injection subcutaneous; second injection lump injections site; Half the dose leaked out of the arm; second injection red injection site; first injection fever; first injection sore arm; A spontaneous report was received from a physician  regarding his wife, a 63-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the injection was given subcutaneously instead of intramuscularly/product administration error, about half of the vaccine leaked out onto her arm/accidental underdose, and lump and redness at injection site/injection site erythema and mass.   The patient's medical history included fever and arm discomfort after first dose. Treatment for these conditions were not reported. No other medical history or concomitant medications were discussed.   On 07 Jan 2021, prior to onset of events the patient received the FIRST of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly for prophylaxis of COVID-19 infection. Reactions included fever and arm soreness.  On 04 Feb 2021, prior to the onset of the events, the patient received the SECOND of two doses of mRNA-1273 (Lot number: 41L20A) SUBCUTANEOUSLY for prophylaxis of COVID-19 infection.    On 04 Feb 2021, as the vaccine was being administered, the physician (husband) noticed that the medical assistant gave the dose subcutaneously instead of intramuscularly and about half the dose leaked out.   Action taken with mRNA-1273 was unknown.  The outcome of the events, injection not given intramuscularly/product administration error, about half of the vaccine leaked out onto her arm/accidental underdose, and lump and redness at injection site/injection site erythema and mass, were considered resolved.; Reporter's Comments: This case concerns a 63 year old, female patient, who experienced a few non-serious events. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. This report also refers to a case of inappropriate route of product administration and accidental underdose for mRNA-1273, lot # 041L20A with no associated AEs. Further information has been requested.
Coughing, itchy throat, headache. BP 150/92, pulse 68. Given Benadryl 25 mg PO.
Patient presents a potential reaction to the COVID19 vaccine. I was called to assess the patient in the vaccination area. Immediately after vaccination, the patient had a vasovagal episode with syncope. Upon my arrival, the patient was alert and had been placed in a supine position with legs elevated. The patient was taking PO hydration and feeling much improved. Per the patient, this is routine for them with vaccination. Plan: Moderate vasovagal episode with syncope, which is common for the patient. We discussed future compensatory measures to avoid these events. The patient was at baseline at discharge and returned home with a partner as the driver.
On the 20th of January I had a mild heartache went to ER they transferred to main hospital, they gave me nitro and then the doctor gave me blood thinners. They placed stint next day then I returned home the following day after stint. No damage to heart and I don't fall into any of the categories to have heart attack, not overweight. I eat healthy.
started having itching 25 min after vaccination, took Benadryl, itching increased, took Pepcid, Tylenol and allegra, continued to itch and Solumedrol 40 mg injection given, followed with more Benadryl and itching  resolved
The patient noted the weakness when he began walking down the stairs, and felt numbness that began from the level of his groin and continued downward.  He also noted right upper extremity weakness as well.  Following the patient's arrival to the ER, he reported that his left side felt numbness beginning, however not at the same level as it was on the right side.
Approximately one month following receipt of booster dose of Moderna COVID-19 vaccine, became aware of persistent, pulsitile, ringing/buzzing in both ears. I have not received any treatment  and the conditions continues at present, unchanged.
Rash over torso looks like measles; Slight itching; This spontaneous case was reported by a patient and describes the occurrence of RASH MORBILLIFORM (Rash over torso looks like measles) and PRURITUS (Slight itching) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal (On blood pressure medication).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced RASH MORBILLIFORM (Rash over torso looks like measles) and PRURITUS (Slight itching). At the time of the report, RASH MORBILLIFORM (Rash over torso looks like measles) was resolving and PRURITUS (Slight itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported. No treatment medication was reported.  Company comment: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Upon internal review on 27-Sep-2022, Non-significant correction was performed to update case level seriousness.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Pt c/o light headiness, dizziness, and tingling at injection site. Pt was instructed to lie down and rest.
Vision loss; Severe Vertigo; Headaches; insomnia; High blood pressure; Tinnitis; Sleep issues; Anxiety; Absolutely feel horrible/Had not feel himself in 90 days; Possible diagnosis of post vaccine psychosis.; Migraine; This is a spontaneous report from a contactable consumer (patient). A 59-years-old male patient received bnt162b2 (BNT162B2) at the age of 59-years-old, dose 2 via an unspecified route of administration, administered in Arm Left on 08Apr2021 15:30 (Batch/Lot Number: ew0162) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The COVID-19 vaccine was administered in Hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The medications the patient received within 2 weeks of vaccination included Trilogy, Flownase Sensimist. Historical Vaccine included BNT162B2 for COVID-19 immunization on 18Mar2021 at the age of 59-year-old (dose 1, product=COVID 19, brand=Pfizer, lot number=ER2613, administration time=16:30, vaccine location=Left arm). The patient experienced vision loss, severe vertigo, headaches, insomnia, high blood pressure, tinnitis, sleep issues, anxiety, absolutely feel horrible, possible diagnosis of post vaccine psychosis on 11Apr2021 07:30, migraine in 2021, with outcome of not recovered. Detail information was as following reported Event: Severe Vertigo, headaches, insomnia, high blood pressure, vision loss, Tinnitis. Vertigo just about 3 days after 2 nd vaccine. Had not feel himself in 90 days. Still experiencing headaches, sleep issues, anxiety. Absolutely feel horrible.  Blood pressure up significantly over historical levels. Being treated for high blood pressure, sleep, anxiety, headaches. Currently seeing a neurologist. Possible diagnosis of post vaccine psychosis. The report was reported as non-serious. The events resulted in Doctor or other healthcare professional office clinic visit Emergency room department or urgent care. Treatment received included Vertigo treatment, Migraine treatment, Ongoing. Since the vaccination, the patient has not been tested for COVID-19.
A report has been received from a Health Professional concerning a 15 year old, Female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 28-Jan-2014. The patient received expired FLUMIST on 28-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
My baby had the the polio, Hib and DTaP vaccines when he was 4 months and was not normal until the 6th day. At 9 mos was his next vaccines and he received the same as 4 mos. He was very lethargic only awake a total of 4 hrs during the day, did not want to nurse or eat, when awake he just cried and fussed and never wanted to be snuggled, very angry never smiled. This now went on for a total of 9 days and the 10th day he seemed to be somewhat normal. Clapping hands and smiling. My other children never were like this and it was kind of scary waiting for him to return to normal or if would ever. I also wonder if the next time he will be worse since each time he gets worse.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. No pertinent medical history, drug reactions or allergies and concomitant medications were reported. On unspecified dates, the unspecified number of patients received improperly stored doses of VAQTA (lot#, expiration date, dose, route of administration and indication were not reported). No adverse effects was reported. This is one of several reports received from the same reporter. Additional information has been requested.
102 degree fever, chills, body ache, dizziness lasted 36-48 hours
what happened was just this injection site was hurting for about 4 days; I just had some fever; Nausea; This is a spontaneous report received from a contactable consumer. This 71-year-old female consumer(patient) reported for herself. A 71-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6199, Expiration Date: 30Jun2021) dose 1 via an unspecified route of administration on 04Mar2021 (at the age of 71-years-old) as dose 1, single for covid-19 immunisation. Medical history included asthma, hypersensitivity, seasonal allergy, hypertension, blood cholesterol increased and mycotic allergy. The patient concomitant medications were not reported. On an unspecified date, the patient experienced what happened was just this injection site was hurting for about 4 days, i just had some fever and nausea. The patient assessed the events as non-serious. The outcome of the events were unknown.  No follow-up attempts are needed. No further information is expected.
Began exhibiting dermatographia-like rash on scalp, neck, trunk, arms, legs on/around 3/07.  Defined welts appeared whenever skin was abraded and subsided within about 15-20 minutes, not itchy unless i scratched more. Inflamed areas were red, warm to touch, blanchable.  I first thought it was an allergic reaction to some unknown substance but elimination and reintroduction of all creams, cosmetics, suspect foods has not resulted in relief or identification of causative agent. Food habits have not changed significantly either in time between vaccination and appearance of symptoms Symptoms made better with use of OTC antihistamine (Cetirizine/Zyrtec) but are otherwise manageable with self-control, not scratching.
redness/swelling @ site (thigh) spreading around leg & up to buttocks maximizing @ 24hr post inj;no fever;
Not reporting an adverse event, but a vaccine failure. Child diagnosed with invasive Streptococcus pneumoniae serotype 19F after receiving all doses of PCV13 for age.
Nine days post vax, the pt was lethargic and limp with a temperature. Mom states baby just stared at the ceiling and would not respond for a period of time, then she would move listlessly and then stare again. Took baby to ER, no treatment was given. Baby was better by the evening of same day.
Itchy red bumpy rash all over body; Itchy red bumpy rash all over body; Itchy red bumpy rash all over body; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 15May2021 at 12:30 as a single dose for COVID-19 immunisation. Medical history included COVID-19 infection. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22May2021, the patient experienced itchy, red and bumpy rash all over body. No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy, red and bumpy rash was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a medical assistant concerning a male patient who was vaccinated with PNEUMOVAX 23 (Lot # 661529/0868X). The medical assistant reported that the patient developed a large, red, swollen reaction at the injection site after receiving the vaccine. The area was so large it hung over the elbow. The date of administration and the date of onset of the symptoms are not available. It is not known if this was the patient's first dose of the vaccine. The physician examined the patient and prescribed prednisone. At the time of the report, the patient had not recovered. The patient sought medical attention at the physician's office. This is one of several reports from the same source. Follow-up information was received on 09-FEB-2009 from the health care worker confirmed that there was one patient that had injection site reaction. She could not provide patient identifiers. Additional information has been requested.
2 1/2-3cm round red macule w/small papules on it @ vax area;
Diagnosed with Mild Stroke; Forgetfulness; A spontaneous report was received from a consumer concerning a 48-year-old, female patient, who experienced  no movement in her eft arm, all the way to her hand and felt no movement in lip or chin. She experienced numbness on the side of her face and was forgetful and Forgetfulness.   The patient's medical history was not provided. Products known to have been used by patient, within two weeks prior to the event, included atorvastatin calcium, acetylsalicylic acid, sodium alginate, sodium bicarbonate, vitamin d and antidepressants.  On 12-FEB-2021, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: Unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 12-MAR-2021, prior to the onset of the events, the patient received her second of two planned doses of mRNA-1273 (Lot number: 003A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 14-MAR-2021, approximately two days after receiving her vaccine, the patient began experiencing no movement in her left arm, all the way to her hand and felt no movement in lip or chin. She experienced numbness on the side of her face and was forgetful. The patient went to the hospital and was diagnosed with a stroke and felt forgetfulness.  On 16-MAR-2021, the patient was discharged from hospital. She was able to use her arm, although her hand was still stiff, and her fingers could move.  Treatments for the events was not reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event, cerebrovascular accident and forgetfulness was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Site: Itching at Injection Site-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient described tingling at injection site after dose given.  He became unresponsive within the 15 minute waiting period and was snoring.  I was able to awaken him and he said he was thirsty and not feeling well.  He was diaphoretic, and very pale.  We called 911 and his wife also.  EMS arrived, took his vitals and he seemd to be responding.  His O2 sat was 93 but his color started to come back and he was starting to feel better.  He did not want to go w/ EMS to hospital and signed a waiver.
Received vaccine past its 30-days Exp date vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received its 30-days Exp date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2022 at 3:37 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Feb-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided No treatment details were provided